Diversified Healthcare Trust (NASDAQ:DHC) Releases FY 2026 Earnings Guidance

Diversified Healthcare Trust (NASDAQ:DHCGet Free Report) issued an update on its FY 2026 earnings guidance on Tuesday. The company provided earnings per share guidance of 0.560-0.620 for the period, compared to the consensus EPS estimate of 0.570. The company issued revenue guidance of -.

Analysts Set New Price Targets

DHC has been the subject of several research analyst reports. Maxim Group lifted their price objective on Diversified Healthcare Trust from $10.00 to $10.50 and gave the stock a “buy” rating in a research report on Wednesday, June 3rd. Royal Bank Of Canada increased their price target on Diversified Healthcare Trust from $6.00 to $8.00 and gave the stock a “sector perform” rating in a report on Thursday. Freedom Capital upgraded shares of Diversified Healthcare Trust to a “strong-buy” rating in a research note on Thursday, April 30th. Wall Street Zen lowered shares of Diversified Healthcare Trust from a “hold” rating to a “sell” rating in a report on Saturday, May 9th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Diversified Healthcare Trust in a research note on Monday, April 20th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Diversified Healthcare Trust has a consensus rating of “Moderate Buy” and a consensus target price of $9.83.

Get Our Latest Research Report on Diversified Healthcare Trust

Diversified Healthcare Trust Trading Up 0.9%

DHC opened at $8.94 on Tuesday. Diversified Healthcare Trust has a one year low of $3.18 and a one year high of $9.14. The company has a debt-to-equity ratio of 1.48, a current ratio of 5.36 and a quick ratio of 5.36. The business has a 50 day simple moving average of $8.24 and a two-hundred day simple moving average of $6.81. The firm has a market capitalization of $2.16 billion, a price-to-earnings ratio of -6.72 and a beta of 2.32.

Diversified Healthcare Trust (NASDAQ:DHCGet Free Report) last released its quarterly earnings results on Monday, May 4th. The real estate investment trust reported ($0.18) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.03). The company had revenue of $366.47 million during the quarter, compared to the consensus estimate of $380.18 million. Diversified Healthcare Trust had a negative return on equity of 18.75% and a negative net margin of 21.10%.Diversified Healthcare Trust has set its FY 2026 guidance at 0.520-0.580 EPS. Analysts predict that Diversified Healthcare Trust will post 0.6 EPS for the current year.

Diversified Healthcare Trust Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, May 14th. Stockholders of record on Tuesday, April 21st were issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend was Tuesday, April 21st. Diversified Healthcare Trust’s dividend payout ratio is presently -3.01%.

Hedge Funds Weigh In On Diversified Healthcare Trust

Several institutional investors and hedge funds have recently bought and sold shares of DHC. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Diversified Healthcare Trust by 4.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 130,756 shares of the real estate investment trust’s stock valued at $314,000 after buying an additional 5,544 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in Diversified Healthcare Trust by 158.9% in the 1st quarter. Goldman Sachs Group Inc. now owns 3,862,334 shares of the real estate investment trust’s stock worth $9,270,000 after purchasing an additional 2,370,459 shares in the last quarter. Strs Ohio bought a new stake in shares of Diversified Healthcare Trust during the first quarter valued at approximately $103,000. JPMorgan Chase & Co. boosted its position in shares of Diversified Healthcare Trust by 10.1% during the second quarter. JPMorgan Chase & Co. now owns 923,963 shares of the real estate investment trust’s stock worth $3,308,000 after acquiring an additional 84,572 shares during the last quarter. Finally, Rhumbline Advisers increased its holdings in Diversified Healthcare Trust by 1.9% in the 2nd quarter. Rhumbline Advisers now owns 388,581 shares of the real estate investment trust’s stock valued at $1,391,000 after acquiring an additional 7,084 shares during the last quarter. 75.98% of the stock is currently owned by hedge funds and other institutional investors.

Diversified Healthcare Trust Company Profile

(Get Free Report)

Diversified Healthcare Trust is a real estate investment trust (REIT) specializing in the acquisition, ownership and management of healthcare properties across the United States. The company focuses on assets that serve the senior housing and post-acute care sectors, including skilled nursing facilities, assisted living communities, memory care centers and medical office buildings. By partnering with experienced operators, Diversified Healthcare Trust aims to generate stable, long-term cash flows through triple-net leases and percentage rent structures tailored to each property type.

The company’s portfolio spans multiple states and encompasses a mix of single-tenant and multi-tenant properties.

Recommended Stories

Receive News & Ratings for Diversified Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diversified Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.